March 11, 2018
Objective: The largest published cohort of aggressive pituitary tumours and carcinomas. Confirms temozolomide as the most effective first-line chemotherapy option for these tumours. Poor efficacy of other drugs highlight need to identify additional treatments for affected patients.
